Impact Factor
2.81
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.98
106 total citations
h5-index
17
h5 depth signal
Cited share
64.3%
36 of 56
Total citations
106
Citation footprint
Metric signal
1.71
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
96
United Kingdom
89
Italy
59
Australia
40
China
39
Citing Fields of Research
Psychiatry
218
Substance Abuse
120
Neurosciences
91
Chronobiology
32
Anesthetic & Pain Medicine
26
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,110
Articles tracked across the journal lifetime
Indexed publication set
56
36 cited publications
Last 12 months
48
4.0 publications/month
Open access share
37.5%
18 OA publications in the last year
Leading citing country
United States
96 citing publications
Leading citing field
Psychiatry
218 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v17n1, Jan. 2002-
v17n1, Jan. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Broad Categories
Psychopharmacology
Psychiatry
Substance Abuse
MeSH Descriptors
Psychopharmacology
Psychotropic Drugs
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/hup.70068
Open DOI
Serum Tau and α‐Synuclein in Children With Attention‐Deficit/Hyperactivity Disorder: Cross‐Sectional Associations With Methylphenidate Treatment
Objective: To compare serum total tau and α‐synuclein among controls, drug‐naïve children with attention‐deficit/hyperactivity disorder (ADHD) and children with ADHD receiving methylphenidate. Methods: Original ELISA spreadsheets provide...
02
DOI 10.1002/hup.70067
Open DOI
Acute Caffeine Intake Does Not Modulate Active or Reactive Inhibition in Non‐Clinical Young Adults, and ADHD Symptoms Do Not Moderate Its Effects
Background: Caffeine is consumed for its presumed cognitive benefits, yet controlled studies have repeatedly failed to find effects on inhibitory control. Cross‐sectional work suggests that people with elevated attention‐deficit/hyperact...
03
DOI 10.1002/hup.70065
Open DOI
Serum Complement Component 4A and Neurofilament Light Chain Levels Before and After Risperidone Monotherapy in Patients With Psychosis
Objective: Recently, complement component 4A (C4A), a complement system protein, and neurofilament light chain (NfL), a neuroaxonal injury biomarker, have been found to be potentially implicated in the pathophysiology of psychosis. This ...
04
DOI 10.1002/hup.70066
Open DOI
Tirzepatide Initiation in Lithium‐Treated Bipolar Disorder: Renal Biomarker Trajectories and Lithium Safety Signals Over 12 Months in a Real‐World Cohort
Objective: To assess early renal and lithium‐related safety and 12‐month renal biomarker trajectories after tirzepatide initiation in lithium‐treated adults with bipolar disorder. Methods: We retrospectively studied 23 adults at one cent...
05
DOI 10.1002/hup.70030
Open DOI
Issue Information
06
DOI 10.1002/hup.70062
Open DOI
Association of Concomitant Amlodipine Use With Serum Olanzapine Concentrations and Clinical Outcomes in Patients With Schizophrenia
Objective: To examine whether concomitant amlodipine use was associated with steady‐state serum olanzapine concentration and clinical outcomes in patients with schizophrenia. Methods: This retrospective study included 45 inpatients with ...
07
DOI 10.1002/hup.70059
Open DOI
A Systematic Review and a VigiBase Study of Accidental Clozapine Intoxications in Children and Adolescents
Objectives: This study aimed to: (1) systematically review published cases of accidental clozapine poisoning in children and adolescents, and (2) study accidental pediatric clozapine intoxications reported to VigiBase, the global pharmac...
08
DOI 10.1002/hup.70064
Open DOI
Correlation Analysis of Blood Lithium Metabolism Kinetics and Concentration‐to‐Dose Ratio in Patients With Hypertension and Manic Episodes
Background: Lithium carbonate has a narrow therapeutic window for the treatment of manic episodes and is mainly excreted via the kidneys. Hypertension may impair lithium clearance, although evidence from relevant studies is insufficient....
09
DOI 10.1002/hup.70063
Open DOI
Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives
Objective: This review critically examines psilocybin, with particular emphasis on its pharmacokinetics and pharmacodynamics, including its serotonergic, neuroplastic, and anti‐inflammatory mechanisms. It integrates historical context, p...
10
DOI 10.1002/hup.70061
Open DOI
Psychopharmacological Mechanisms of Antidepressant Withdrawal: Insights From Venlafaxine
Antidepressant discontinuation syndrome (ADS) is widely reported yet often minimized by terminology that obscures its status as a withdrawal phenomenon. Roughly one‐third of patients using a monotherapy antidepressant develop withdrawal ...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 27 (2012)
Supplements accompany some vols.
Also issued online